An older person in a knitted sweater filling a colorful weekly pill organizer at a table, with blister packs beside it
Photo: Yaroslav Shuraev / Pexels

Published October 21, 2026 · The RxVue Editorial Team · fact-checked against the sources below

It usually starts with a small, practical problem. An elderly parent has started to struggle with large tablets, or a relative mentions that a care home crushes some tablets into a spoonful of something soft, and it seems like an easy fix at home too. Then someone mentions the do not crush list, and the fix no longer looks so simple.

The do not crush list is a reference of oral medicines, mostly extended-release, enteric-coated, sublingual or irritating ones, that should not be crushed, chewed or opened because doing so changes how they work. Letters such as ER, XR, SR, CR, XL and EC are warning signs, but some products carry none, so a pharmacist checks each medicine.

What the do not crush list is, and where it went

The list most people have in mind is a long table of brand and generic products, each with the reason it should not be crushed. According to a 2023 review in the journal Drugs and Aging, it was first published in 1982, updated periodically, and was available from the Institute for Safe Medication Practices (ISMP) until November 2022. It is now available from a commercial publisher, Thomas Land Publishers.

That history matters for one practical reason. Printouts of the old version still circulate on care home walls and in caregiver folders, and a list that stopped being updated in 2022 cannot include medicines launched since. Treat any printed copy as a prompt to ask, not as a final answer. The most current check for any specific medicine is its own labeling and the pharmacist who dispensed it.

Why some tablets have to stay whole

A tablet is not always just medicine pressed into a convenient shape. Many are engineered to control where and how fast the medicine is released, and crushing undoes that engineering. ISMP’s guidance for long-term care, and the 2023 review, group the reasons into a handful of families.

  • Extended or sustained release. These tablets and capsules are built to release their contents gradually over many hours. ISMP explains that crushing or splitting them can cause the immediate release of an amount that was meant to be released over a much longer period. Capsules containing slow-release beads fall into the same family, because crushing the beads defeats them.
  • Enteric coating. An enteric coating protects the medicine from stomach acid and delays its release until it reaches the small intestine. Crushing the tablet exposes the medicine in the stomach, where it may be broken down or irritate the stomach lining.
  • Sublingual, buccal and effervescent forms. Tablets designed to dissolve under the tongue, in the cheek, or in water are meant to be used exactly that way. The 2023 review lists sublingual and buccal forms among those not to crush, and ISMP notes that crushing sublingual or effervescent tablets can reduce how well they work.
  • Irritants. A few medicines can irritate the mouth, throat or esophagus if they are broken up instead of swallowed whole.
  • Hazardous medicines. Some medicines, including many oral cancer treatments, can harm the person handling them if crushed into a powder that can be inhaled or touched. ISMP says these should only be altered with special precautions, in a pharmacy.
  • Taste. The 2023 review lists a potentially unacceptable taste as a reason on its own, since a bitter powder can make someone refuse the medicine entirely.

The same reasoning shows up in FDA’s rules for scored tablets. FDA’s guidance says modified-release products whose control of drug release could be compromised by splitting should not have a scoring feature at all, and FDA’s consumer page notes that most sustained, controlled or timed release medicines are not meant for splitting. A line across a tablet means something specific, as explained in what a scored tablet is, and on these products it is usually absent for a reason.

The letters on the label that warn you

The most useful thing a caregiver can learn from ISMP’s guidance is the set of prefixes and suffixes that commonly mark extended or sustained release products. They appear after or before the medicine’s name on the pharmacy label and the manufacturer’s box. ISMP lists these, among others:

12-hour, 24-hour, CC, CD, CR, DUR, ER, LA, Retard, SA, Slo-, SR, TD, TR, XL, XR and XT.

You do not need to know what each one stands for. Most are shorthand for extended release (ER, XR, XL), sustained release (SR) or controlled release (CR), and ISMP groups them all under the same warning: a tablet labeled extended-release or sustained-release should not be crushed or split. For enteric coating, ISMP lists EC and EN as common markers.

Two cautions come with the list. First, ISMP is explicit that some extended-release products carry no prefix or suffix at all, and that some enteric-coated products are not marked either, so the absence of letters proves nothing. Second, these letters matter when a prescription changes. If a medicine switches from one manufacturer’s version to another, or from an immediate-release form to an extended-release one, the rules for that tablet can change with it. Brand and generic versions share an active ingredient but not necessarily every feature of the tablet, as covered in generic vs brand name drugs.

When swallowing is the real problem

For most families this comes up because swallowing has become difficult, and the goal is to solve that without guesswork. The NHS guidance on problems swallowing pills is clear on both halves: do not crush pills, open capsules or alter a medicine without getting advice first, because it could stop the medicine working properly, and do ask a pharmacist, who can advise about other versions of the medicine that may be available, such as a liquid or a dissolvable tablet.

That second half is the useful one. Many medicines exist in more than one form, and a prescriber can often switch to a liquid, a smaller tablet, or a form designed to dissolve, which removes the need to crush anything. The pharmacist is also the right person to say which of the current medicines, if any, can be altered, and how.

ISMP’s advice to care homes translates well to a household. It recommends asking the pharmacy to put a prominent “do not crush or split” warning on the label of any medicine that should stay whole, and to spell out “sustained release” or “enteric coated” on the label when those words are not already part of the medicine’s name. A family can ask for exactly the same thing.

Building it into a caregiver’s system

The practical version of all this fits into a system most caregivers already have. When you keep a master list of someone’s medicines, add one column: can this be crushed, split or opened, as confirmed by the pharmacist, with the date you asked. The medication list template has space for it, and the wider setup is covered in medication management for elderly parents.

A few habits make the column reliable:

  • Ask at every change. A new medicine, a new strength, or a new manufacturer is a new question, even if the old version could be crushed.
  • Ask about the whole list at once. A pharmacist can go through every medicine in one conversation, which is quicker than asking one at a time as problems arise.
  • Keep the answer with the medicines. A note in the pill organizer lid or on the cabinet door means anyone helping, including a visiting relative, sees it before they reach for a spoon.

If a tablet has already been crushed and the person seems unwell, do not wait to identify anything: contact the prescriber, call Poison Help on 1-800-222-1222 in the United States, or call emergency services if the situation is urgent. For everything else, the do not crush question is a quick one, and a pharmacist can answer it before it ever becomes a problem.

Sources